Tower Research Capital (TRC)’s Dogwood Therapeutics DWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.5K Buy
7,036
+3,943
+127% +$7.1K ﹤0.01% 4363
2026
Q2
$4.98K Sell
3,093
-4,974
-62% -$8.24K ﹤0.01% 4321
2026
Q1
$17K Buy
+8,067
New +$23.7K ﹤0.01% 3594
2025
Q4
– Sell
-744
Closed -$5.73K – 5719
2025
Q3
$5.73K Sell
744
-48
-6% -$239 ﹤0.01% 4206
2025
Q2
$3.78K Sell
792
-258
-25% -$1.25K ﹤0.01% 4436
2025
Q1
$5.26K Buy
1,050
+78
+8% +$528 ﹤0.01% 4138
2024
Q4
$2.42K Buy
972
+699
+256% +$2.32K ﹤0.01% 4845
2024
Q3
$1.16K Sell
273
-2
-0.7% -$10 ﹤0.01% 5197
2024
Q2
$1.48K Buy
275
+3
+1% +$26 ﹤0.01% 5153
2024
Q1
$3.26K Buy
272
+4
+1% +$45 ﹤0.01% 4895
2023
Q4
$3.86K Sell
268
-83
-24% -$1.4K ﹤0.01% 5035
2023
Q3
$8.11K Buy
351
+260
+286% +$9.04K ﹤0.01% 4390
2023
Q2
$3.16K Buy
+91
New +$2.6K ﹤0.01% 5101
2022
Q3
– Sell
-59
Closed -$6K – 6571
2022
Q2
$6K Sell
59
-46
-44% -$4.81K ﹤0.01% 4969
2022
Q1
$12K Buy
105
+104
+10,400% +$15.1K ﹤0.01% 4109
2021
Q4
$0 Sell
1
-95
-99% -$12.1K ﹤0.01% 6649
2021
Q3
$13K Buy
96
+35
+57% +$4.84K ﹤0.01% 4108
2021
Q2
$10K Buy
61
+33
+118% +$4.68K ﹤0.01% 4407
2021
Q1
$4K Buy
+28
New +$4.87K ﹤0.01% 4817

Other funds holding DWTX

Tower Research Capital (TRC)'s DWTX Position: Q3 2026 in Review

Tower Research Capital (TRC) increased its Dogwood Therapeutics (DWTX) stake by 127% in Q3 2026, buying an estimated $7.1K and bringing the position to 7,036 shares worth $9.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4363.

Tower Research Capital (TRC) first reported a position in DWTX in Q1 2021 and has held it in 19 quarters since. The position peaked at $17K in Q1 2026. 22 funds tracked by Wall St. Rank hold DWTX as of Q3 2026.

  • Tower Research Capital (TRC) held 7,036 shares of Dogwood Therapeutics worth $9.5K as of Q3 2026.
  • Tower Research Capital (TRC) bought 3,943 Dogwood Therapeutics shares in Q3 2026, an estimated $7.1K.
  • Dogwood Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #4363 holding.
  • Tower Research Capital (TRC) first reported a position in Dogwood Therapeutics in Q1 2021 and has held it in 19 quarters since.
  • Tower Research Capital (TRC)'s Dogwood Therapeutics position peaked at $17K in Q1 2026.
  • 22 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.